Maternal valacyclovir and infant cytomegalovirus acquisition: A randomized controlled trial among HIV-infected women

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Roxby, Alison C ^a   Atkinson, Claire ^c   Ásbjörnsdóttir, Kristjana ^a   Farquhar, Carey ^a   Kiarie, James N ^e   Drake, Alison L ^a   Wald, Anna ^a,f   Boeckh, Michael ^a,f   Richardson, Barbra ^a,f   Emery, Vincent ^d   John Stewart, Grace ^a,b   Slyker, Jennifer A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEVIRAPINE; PLACEBO; VALACICLOVIR; VIRUS DNA; ZIDOVUDINE; ACICLOVIR; ANTIVIRUS AGENT; VALINE;

ARTICLE; BREAST MILK; CD4 LYMPHOCYTE COUNT; CHILDBIRTH; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; DOUBLE BLIND PROCEDURE; DRIED BLOOD SPOT TESTING; FEMALE; GESTATION PERIOD; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; NONHUMAN; PREGNANT WOMAN; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT DURATION; VAGINAL SECRETION; VERTICAL TRANSMISSION; VIRUS DETECTION; VIRUS SHEDDING; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEWBORN; PREGNANCY; PREMEDICATION; PREVENTION AND CONTROL; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ACYCLOVIR; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIV SEROPOSITIVITY; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN; PREGNANCY; PREMEDICATION; TREATMENT OUTCOME; VALINE; VIRAL LOAD; VIRUS SHEDDING;

EID: 84895167555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087855     Document Type: Article

References (23)

1. Gompels UA, Larke N, Sanz-Ramos M, Bates M, Musonda K, et al. (2012) Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis 54: 434-442.
2. Slyker JA, Lohman-Payne BL, John-Stewart GC, Maleche-Obimbo E, Emery S, et al. (2009) Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS 23: 2173-2181.
3. Kapetanovic S, Aaron L, Montepiedra G, Burchett SK, Kovacs A (2012) T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children. AIDS 26: 959-969.
4. Kovacs A, Schluchter M, Easley K, Demmler G, Shearer W, et al. (1999) Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 341: 77-84.
5. Kaye S, Miles D, Antoine P, Burny W, Ojuola B, et al. (2008) Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia. J Infect Dis 197: 1307-1314. (Pubitemid 351632762)
6. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK (2013) The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev 26: 86-102.
7. Winston DJ, Wirin D, Shaked A, Busuttil RW (1995) Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 346: 69-74.
8. Feinberg JE, Hurwitz S, Cooper D, Sattler FR, MacGregor RR, et al. (1998) A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis 177: 48-56. (Pubitemid 28030433)
9. Emery VC, Sabin C, Feinberg JE, Grywacz M, Knight S, et al. (1999) Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis 180: 695-701. (Pubitemid 29411354)
10. Drake AL, Roxby AC, Ongecha-Owuor F, Kiarie J, John-Stewart G, et al. (2012) Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial. J Infect Dis 205: 366-375.
11. Atkinson C, Walter S, Sharland M, Tookey P, Luck S, et al. (2009) Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol 81: 1394-1398.
12. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, et al. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775. (Pubitemid 28194317)
13. Frederick T, Homans J, Spencer L, Kramer F, Stek A, et al. (2012) The Effect of Prenatal Highly Active Antiretroviral Therapy on the Transmission of Congenital and Perinatal/Early Postnatal Cytomegalovirus Among HIV-Infected and HIV-Exposed Infants. Clin Infect Dis.
14. Guibert G, Warszawski J, Le Chenadec J, Blanche S, Benmebarek Y, et al. (2009) Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy. Clin Infect Dis 48: 1516-1525.
15. Glennie SJ, Nyirenda M, Williams NA, Heyderman RS (2012) Do multiple concurrent infections in African children cause irreversible immunological damage? Immunology 135: 125-132.
16. Gantt S, Carlsson J, Shetty AK, Seidel KD, Qin X, et al. (2008) Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis. AIDS 22: 1453-1460.
17. Griffiths PD (2006) CMV as a cofactor enhancing progression of AIDS. J Clin Virol 35: 489-492.
18. Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG (2005) Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 143: 870-880. (Pubitemid 46202222)
19. Jacquemard F, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, et al. (2007) Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 114: 1113-1121. (Pubitemid 47247017)
20. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, et al. (2009) HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS 23: 479-483.
21. Shen CY, Chang SF, Yen MS, Ng HT, Huang ES, et al. (1993) Cytomegalovirus excretion in pregnant and nonpregnant women. J Clin Microbiol 31: 1635-1636.
22. Mostad SB, Kreiss JK, Ryncarz A, Chohan B, Mandaliya K, et al. (2000) Cervical shedding of herpes simplex virus and cytomegalovirus throughout the menstrual cycle in women infected with human immunodeficiency virus type 1. Am J Obstet Gynecol 183: 948-955.
23. Drake AL, Roxby AC, Kiarie J, Richardson BA, Wald A, et al. (2012) Infant Safety during and after Maternal Valacyclovir Therapy in Conjunction with Antiretroviral HIV-1 Prophylaxis in a Randomized Clinical Trial. PLoS One 7: e34635.